The rapid breakdown of glucose (glycolysis) in venous blood samples is very significant for the diagnosis of both diabetes mellitus and gestational diabetes which should be detected at an early stage to avoid complications such as infections, premature births and long-term effects for the mother and child. In order to have a reliable diagnosis, it is necessary to inhibit glucose breakdown immediately after collecting blood. Various institutions have drafted guidelines, which recommend the addition of a citrate-fluoride additive to maintain the “in vivo glucose level”. The special feature of the new VACUETTE FC Mix tube from Greiner Bio-One is the powder additive. It stabilizes the glucose level immediately after collection for 48 hours. This allows for reliable diagnosis of diabetes conditions and avoids false negatives. The stabilization is carried out in the whole blood and therefore does not require immediate centrifugation. Unlike in tubes where liquid is added, the finely granulated additive does not cause a dilution effect. There is no need to convert the measurement result. The citrate/citric acid buffer reduces the pH value in the sample. As a result, the enzymes needed for the glycolysis process are inhibited and the actual “in vivo level” is stabilized from the start. The additive is completely dissolved, and therefore optimally mixed with the sample, after swivelling ten times. In the case of storage between 4°C and room temperature, a further sodium fluoride additive ensures long-term stabilization for 48 hours. The VACUETTE FC Mix tube is available with both a grey and pink security cap and therefore allows for differentiation from standard glucose tubes. The cap is particularly easy to open and allows for hygienic working in the laboratory. The VACUETTE FC Mix tube is made of highly-transparent PET plastic and is shatter-proof.
Read more

Urine analysis is an integral part of laboratory routine and constitutes a first window to assess the individual physiological and metabolic state.  All kinds of parameters have been progressively included in urine analysis, many of them present both in serum and in urine. Problems may arise when assessing the accuracy of results, because the user often only has serum matrix controls. So matrix commutability (analysis results independently from matrix type) is not guaranteed. Currently, general recommendations advocate the use of control material with identical (or similar) matrix to the one of the analysed sample whenever possible. Aware of this situation, Biosystems S.A. has developed a Multiparametric Urine Control specific for biochemistry tests (Albumin, alpha Amylase, alpha Amylase Pancreatic, Calcium, Chloride, Citrate, Creatinine, Glucose, Magnesium, Phosphorus, Potassium, Protein Urine, Sodium, Urea and Uric Acid).  Values have been assigned using the recommended International Reference standards. This ensures traceability of results and comparison between laboratories. The urine control is lyophilized to guarantee maximum stability (expiration date of 24 months, 1 month at -20ºC after reconstitution) without matrix interferents. Along with this Biochemistry Urine Control, BioSystems also offers a specific Urine Contol for the analysis of metabolites (5-ALA, 5-HIIA, 17-OH, 17-KETO, VMA, Metanephrines), which completes its range for routine urine analysis in all kind of laboratories.

Read more

The NEXgen ELISA system provides total automation of microELISA testing.  The instrument is able to process 7 ELISA assay microplates simultaneously. The flexible assay environment with user friendly user interface makes the analyser particularly suitable for laboratories with a daily versatile work routine, process a wide variety of parameters in addition to high-volume sample testing. Features of the system include high speed pipetting, continuous loading of samples, minimum operator training and reliable data processing. All EIAgen microELISA assays are validated and preprogrammed. The analyser has also been designed for IFA technology adaptation.

Read more

MP Diagnostics’ newly launched MULTISURE Range consists of three separate devices for the diagnosis of diseases that are of major health concern: Dengue, HIV and HCV. The MULTISURE rapid tests are qualitative immunochromatographic assays intended for the screening of dengue, HIV and HCV infections and are equipped with MP Diagnostics’ patented reverse flow technology. The patented reverse flow technology enhances visual identification for easier interpretation of results. MP Diagnostics’ ASSURE Reader and ASSURE Palm Reader are developed for use with the MULTISURE range of rapid tests and are fully integrated instruments designed for the institution’s needs. The MP ASSURE readers complement the reading and documentation of results for both laboratory and point-of-care settings. With the latest upgrade in software, the MP ASSURE readers’ integration to management systems would be seamless for all users.

The new test range is for research use only in the United States.

Read more

Randox is one of the largest manufacturers of complete QC solutions designed to suit the needs of even the most demanding laboratories. Comprising true third party controls, interlaboratory data management and the world’s largest global EQA scheme we can help you achieve ISO 15189 accreditation.

• Acusera – True Third Party Controls
  Our multi-analyte controls deliver consolidation and cost savings without compromising on quality.  Covering clinical decision levels and providing a matrix similar to patient samples you can be sure ISO 15189 requirements are met.

• Acusera 24.7 – Interlaboratory Data Management
  With Acusera 24.7 Live Online you can now effectively monitor and interpret your daily QC data, compare to worldwide peer group statistics and generate charts for enhanced bench review. 

• RIQAS – The World’s Largest Global EQA Scheme
  Covering almost 360 parameters in 24 comprehensive and flexible EQA programmes, RIQAS is designed to cover all areas of clinical testing. Each programme benefits from a wide range of concentrations, frequent reporting and comprehensive yet user-friendly reports.

For more info click here
Read more